Interactions between Innate Immunity, Microbiota, and Probiotics

Journal of Immunology Research

Volumn 2015, Issue , 2015, Pages

  Giorgetti, GianMarco ^a   Brandimarte, Giovanni ^b   Fabiocchi, Federica ^a   Ricci, Salvatore ^c   Flamini, Paolo ^c   Sandri, Giancarlo ^a   Trotta, Maria Cristina ^a   Elisei, Walter ^d   Penna, Antonio ^e   Lecca, Piera Giuseppina ^b   Picchio, Marcello ^f   Tursi, Antonio ^g  

^a S EUGENIO HOSPITAL   (Italy)

^b Cristo Re Hospital   (Italy)

^c POLICLINICO UMBERTO I   (Italy)

^d ASL Roma H   (Italy)

^e S Paolo Hospital ^*  (Italy)

^f Hospital P Colombo   (Italy)

^g ASL BAT   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; BETA DEFENSIN; CATHELICIDIN; GLYCOSIDASE; LECTIN; PROBIOTIC AGENT; RIBONUCLEASE; TOLL LIKE RECEPTOR;

BACTERIAL FLORA; BACTERIAL STRAIN; DOWN REGULATION; ENTERITIS; HOMEOSTASIS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; INNATE IMMUNITY; INTESTINE EPITHELIUM; NONHUMAN; PANETH CELL; PROTEIN SECRETION; PROTEIN SYNTHESIS; REGULATORY T LYMPHOCYTE; REVIEW; STIMULUS RESPONSE; ANIMAL; DRUG EFFECTS; IMMUNOLOGY; MICROBIOLOGY; MICROFLORA;

ANIMALS; HUMANS; IMMUNITY, INNATE; MICROBIOTA; PANETH CELLS; PROBIOTICS;

EID: 84930959973     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2015/501361     Document Type: Review

References (37)

1. S. R. Gill, M. Pop, R. T. DeBoy et al., "Metagenomic analysis of the human distal gut microbiome," Science, vol. 312, no. 5778, pp. 1355-1359, 2006.
2. S. Cucchiara, V. Iebba, M. P. Conte, and S. Schippa, "The microbiota in inflammatory bowel disease in different age groups," Digestive Diseases, vol. 27, no. 3, pp. 252-258, 2009.
3. J. P. Ouwerkerk, W. M. de Vos, and C. Belzer, "Glycobiome: bacteria and mucus at the epithelial interface," Best Practice and Research: Clinical Gastroenterology, vol. 27, no. 1, pp. 25-38, 2013.
4. M. E. V. Johansson, M. Phillipson, J. Petersson, A. Velcich, L. Holm, and G. C. Hansson, "The inner of the two Muc2 mucin-dependentmucus layers in colon is devoid of bacteria," Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 39, pp. 15064-15069, 2008.
5. A. Baghaei, H. Esmaily, A. H. Abdolghaffari, M. Baeeri, F. Gharibdoost, and M. Abdollahi, "Efficacy of Setarud (IMOD), a novel drug with potent anti-toxic stress potential in rat inflammatory bowel disease and comparison with dexamethasone and infliximab," Indian Journal of Biochemistry and Biophysics, vol. 47, no. 4, pp. 219-226, 2010.
6. A. Swidsinski, V. Loening-Baucke, and A. Herber, "Mucosal flora in Crohn's disease and ulcerative colitis - an overview," Journal of Physiology and Pharmacology, vol. 60, no. 6, pp. 61-71, 2009.
7. B. P. Ganesh, R. Klopfleisch, G. Loh, and M. Blaut, "Commensal Akkermansia muciniphila exacerbates gut inflammation in Salmonella Typhimurium-infected gnotobiotic mice," PLoS ONE, vol. 8, no. 9, Article ID e74963, 2013.
8. C. Rumio, D. Besusso, M. Palazzo et al., "Degranulation of Paneth cells via Toll-like receptor 9," The American Journal of Pathology, vol. 165, no. 2, pp. 373-381, 2004.
9. C. Rumio, M. Sommariva, L. Sfondrini et al., "Induction of Paneth cell degranulation by orally administered Toll-like receptor ligands," Journal of Cellular Physiology, vol. 227, no. 3, pp. 1107-1113, 2012.
10. N. H. Salzman, K. Hung, D. Haribhai et al., "Enteric defensins are essential regulators of intestinal microbial ecology," Nature Immunology, vol. 11, no. 1, pp. 76-83, 2010.
11. N. H. Salzman, D. Ghosh, K. M. Huttner, Y. Paterson, and C. L. Bevins, "Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin," Nature, vol. 422, no. 6931, pp. 522-526, 2003.
12. J. Lee, J.-H. Mo, K. Katakura et al., "Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells," Nature Cell Biology, vol. 8, no. 12, pp. 1327-1336, 2006.
13. S. Rakoff-Nahoum, J. Paglino, F. Eslami-Varzaneh, S. Edberg, and R. Medzhitov, "Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis," Cell, vol. 118, no. 2, pp. 229-241, 2004.
14. I. I. Ivanov, K. Atarashi, N. Manel et al., "Induction of intestinal Th17 cells by segmented filamentous bacteria," Cell, vol. 139, no. 3, pp. 485-498, 2009.
15. C. Cremon, L. Zecchi, M. R. Barbato et al., "843 Mucosal immune biomarkers in patients with irritable bowel syndrome," Gastroenterology, vol. 144, no. 5, supplement 1, p. S-150, 2013.
16. C. Martínez, B. Lobo, M. Pigrau et al., "Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier," Gut, vol. 62, no. 8, pp. 1160-1168, 2013.
17. I. Sekirov, S. L. Russell, L. Caetano M Antunes, and B. B. Finlay, "Gut microbiota in health and disease," Physiological Reviews, vol. 90, no. 3, pp. 859-904, 2010.
18. K. Tsilingiri, T. Barbosa, G. Penna et al., "Probiotic and postbiotic activity in health and disease: comparison on a novel polarised ex-vivo organ culture model," Gut, vol. 61, no. 7, pp. 1007-1015, 2012.
19. H. Sokol, B. Pigneur, L. Watterlot et al., "Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients," Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 43, pp. 16731-16736, 2008.
20. F. Ammoscato, A. Scirocco, A. Altomare et al., "Lactobacillus rhamnosus protects human colonic muscle from pathogen lipopolysaccharide-induced damage," Neurogastroenterology and Motility, vol. 25, no. 12, pp. e984-e777, 2013.
21. T. Ha, Y. Hu, L. Liu et al., "TLR2 ligands induce cardioprotection against ischaemia/reperfusion injury through a PI3K/Akt-dependent mechanism," Cardiovascular Research, vol. 87, no. 4, pp. 694-703, 2010.
22. M. G. Gareau, P. M. Sherman, and W. A. Walker, "Probiotics and the gut microbiota in intestinal health and disease," Nature Reviews: Gastroenterology & hepatology, vol. 7, no. 9, pp. 503-514, 2010.
23. E. Mileti, G. Matteoli, I. D. Iliev, and M. Rescigno, "Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy," PLoS ONE, vol. 4, no. 9, Article ID e7056, 2009.
24. L.-L. Chen, X.-H. Wang, Y. Cui et al., "Therapeutic effects of four strains of probiotics on experimental colitis in mice," World Journal of Gastroenterology, vol. 15, no. 3, pp. 321-327, 2009.
25. C. Di Giacinto, M. Marinaro, M. Sanchez, W. Strober, and M. Boirivant, "Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-β-bearing regulatory cells," The Journal of Immunology, vol. 174, no. 6, pp. 3237-3246, 2005.
26. G. M. Cobrin and M. T. Abreu, "Defects in mucosal immunity leading to Crohn's disease," Immunological Reviews, vol. 206, pp. 277-295, 2005.
27. C. Pagnini, R. Saeed, G. Bamias, K. O. Arseneau, T. T. Pizarro, and F. Cominelli, "Probiotics promote gut health through stimulation of epithelial innate immunity," Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 1, pp. 454-459, 2010.
28. P. Nava, S. Koch, M. G. Laukoetter et al., "Interferon-gamma regulates intestinal epithelial homeostasis through converging beta-catenin signaling pathways," Immunity, vol. 32, no. 3, pp. 392-402, 2010.
29. M. Schlee, J. Wehkamp, A. Altenhoefer, T. A. Oelschlaeger, E. F. Stange, and K. Fellermann, "Induction of human β-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin," Infection and Immunity, vol. 75, no. 5, pp. 2399-2407, 2007.
30. M. Möndel, B. O. Schroeder, K. Zimmermann et al., "Probiotic E. coli treatment mediates antimicrobial human β-defensin synthesis and fecal excretion in humans," Mucosal Immunology, vol. 2, no. 2, pp. 166-172, 2009.
31. N. S. Dykstra, L. Hyde, D. Adawi et al., "Pulse probiotic administration induces repeated small intestinal Muc3 expression in rats," Pediatric Research, vol. 69, no. 3, pp. 206-211, 2011.
32. D. R. Mack, S. Michail, S. Wei, L. McDougall, and M. A. Hollingsworth, "Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression," American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 276, no. 4, pp. G941-G950, 1999.
33. K. Tsilingiri and M. Rescigno, "Postbiotics: what else?" Beneficial Microbes, vol. 4, no. 1, pp. 101-107, 2013.
34. A. Canonici, C. Siret, E. Pellegrino et al., "Saccharomyces boulardii improves intestinal cell restitution through activation of the α2β1 integrin collagen receptor," PLoS ONE, vol. 6, no. 3, Article ID e18427, 2011.
35. S. Segawa, M. Fujiya, H. Konishi et al., "Probiotic-derived polyphosphate enhances the epithelial barrier function and maintains intestinal homeostasis through integrin-p38 MAPK pathway," PLoS ONE, vol. 6, no. 8, Article ID e23278, 2011.
36. F. Yan, H. Cao, T. L. Cover et al., "Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism," The Journal of Clinical Investigation, vol. 121, no. 6, pp. 2242-2253, 2011.
37. D. Corridoni, L. Pastorelli, B. Mattioli et al., "Probiotic bacteria regulate intestinal epithelial permeability in experimental ileitis by a TNF-dependent mechanism," PLoS ONE, vol. 7, no. 7, Article ID e42067, 2012.